Kai Fu
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 75
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 39
- Oncology top 2%
- Viral-associated cancers and disorders 24
- CAR-T cell therapy research 10
- Cancer Research top 5%
- Neurology top 5%
- CNS Lymphoma Diagnosis and Treatment 10
-
- Cutaneous lymphoproliferative disorders research 9
-
- Immune Cell Function and Interaction 8
-
- Acute Myeloid Leukemia Research 7
Kai Fu
142 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Pathology and Forensic Medicine 1.9k
- Genetics 866
- Oncology 1.4k
- Cancer Research 466
- Neurology 348
Countries citing papers authored by Kai Fu
This map shows the geographic impact of Kai Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Fu more than expected).
Fields of papers citing papers by Kai Fu
This network shows the impact of papers produced by Kai Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Fu. The network helps show where Kai Fu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kai Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 12 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 2 | |
| 8 | 2021 | 1 | |
| 9 | 2019 | 24 | |
| 10 | 2019 | 27 | |
| 11 | 2017 | 1 | |
| 12 | 2016 | 8 | |
| 13 | 2015 | 54 | |
| 14 | 2014 | 30 | |
| 15 | 2014 | 14 | |
| 16 | 2012 | 46 | |
| 17 | 2011 | 29 | |
| 18 | [Prevalence of germinal center B-cell-like and non-germinal center B-cell-like types of diffuse large B-cell lymphoma in Shanghai, China]. | 2010 | 6 |
| 19 | 2008 | 27 | |
| 20 | 2007 | 22 |
About Kai Fu
Kai Fu is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Dermatology and Hematology, having authored 152 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (75 papers), Chronic Lymphocytic Leukemia Research (39 papers), Viral-associated cancers and disorders (24 papers), CNS Lymphoma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (10 papers), Cutaneous lymphoproliferative disorders research (9 papers), Immune Cell Function and Interaction (8 papers) and Acute Myeloid Leukemia Research (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.9k citations), Genetics (866 citations), Oncology (1.4k citations), Cancer Research (466 citations) and Neurology (348 citations). Kai Fu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Wing C. Chan, Dennis D. Weisenburger, Timothy C. Greiner, Julie M. Vose, Lynette M. Smith, Liwu Fu, Fang Wang, Javeed Iqbal, Jamés O. Armitage and Timothy W. McKeithan. Their work appears in journals such as Blood, American Journal of Clinical Pathology, British Journal of Haematology, Archives of Pathology & Laboratory Medicine and The American Journal of Surgical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.